Natera, Inc. (NTRA)
Health Care ยท Services-Medical Laboratories
Natera, Inc. (NTRA) is listed on Nasdaq, where its shares have traded since July 2, 2015. SentiSense covers Natera, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories. Steve Chapman is its chief executive officer. The company reports 6,140 employees, and its corporate website is www.natera.com.
About Natera, Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 830 institutions reported holding NTRA, with 136.4 million shares worth $37.0 billion in aggregate. The largest reported holders were Vanguard, JPMorgan Chase and BlackRock. Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter.
More on NTRA
- NTRA sentiment: whether news and social coverage of Natera, Inc. leans bullish or bearish, and the stories driving it.
- NTRA ownership: all 830 reporting institutions, plus insider and congressional trades.
- NTRA financials: revenue, net income, operating margin and free cash flow by quarter and year.
SentiSense also tracks daily options readings for Natera, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Natera, Inc. do?
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology.
What sector is NTRA in?
SentiSense classifies Natera, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories.
Where does NTRA stock trade?
Natera, Inc. (NTRA) is listed on Nasdaq, where its shares have traded since July 2, 2015.
Who is the CEO of Natera, Inc.?
Steve Chapman is the chief executive officer of Natera, Inc..